For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.
Adverse Events Module path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Groups
Study -> Results Section -> Adverse Events Module -> Serious Events
Study -> Results Section -> Adverse Events Module -> Other Events
| Title | Description | Deaths # Affected | Deaths # At Risk | Serious # Affected | Serious # At Risk | Other # Affected | Other # At Risk | View |
|---|---|---|---|---|---|---|---|---|
| Ellipse VR With Durata | Ellipse VR single-chamber ICD with a Durata defibrillation lead Study MRI scan: At least forty-five (45) days after system implantation or after a system revision, Subjects will undergo a study-related MRI scan at 1.5T. | 0 | None | 2 | 14 | 0 | 14 | View |
| Ellipse DR With Durata & Tendril STS | Ellipse DR dual-chamber ICD with a Durata lead in the right ventricle (RV) and a Tendril STS lead in the right atrium (RA). Study MRI scan: At least forty-five (45) days after system implantation or after a system revision, Subjects will undergo a study-related MRI scan at 1.5T. | 0 | None | 3 | 14 | 0 | 14 | View |
| Ellipse DR With Optisure and Isoflex | Ellipse DR dual-chamber ICD with an Optisure defibrillation lead in the right ventricle (RV) and an Isoflex lead in the right atrium (RA). Study MRI scan: At least forty-five (45) days after system implantation or after a system revision, Subjects will undergo a study-related MRI scan at 1.5T. | 0 | None | 2 | 15 | 1 | 15 | View |
| Quadra Assura MP CRT-D | Quadra Assura MP CRT-D with an Optisure or Durata defibrillation lead in the RV, an Isoflex or Tendril STS lead in the RA, and a Quartet lead in the LV Study MRI scan: At least forty-five (45) days after system implantation or after a system revision, Subjects will undergo a study-related MRI scan at 1.5T. | 0 | None | 1 | 12 | 0 | 12 | View |
| Term | Type | Organ System | Vocab | View |
|---|---|---|---|---|
| OTHER: CERVICAL SPONDYLOSIS | SYSTEMATIC_ASSESSMENT | Musculoskeletal and connective tissue disorders | None | View |
| OTHER:HEART FAILURE | SYSTEMATIC_ASSESSMENT | Cardiac disorders | None | View |
| OTHER:Chronic obstructive pulmonary disease | SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | None | View |
| OTHER: CAROTID SCLEROSIS | SYSTEMATIC_ASSESSMENT | Cardiac disorders | None | View |
| OTHER: HYPERKALEMIA | SYSTEMATIC_ASSESSMENT | Renal and urinary disorders | None | View |
| OTHER: DILATED CARDIOMYOPATHY | SYSTEMATIC_ASSESSMENT | Cardiac disorders | None | View |
| OTHER:INAPPROPIATE SHOCK | SYSTEMATIC_ASSESSMENT | Product Issues | None | View |
| Term | Type | Organ System | Vocab | View |
|---|---|---|---|---|
| OTHER: VENTRICULAR FIBRILLATION | SYSTEMATIC_ASSESSMENT | Cardiac disorders | None | View |